Breaking News
September 22, 2018 - Why Eczema Is Tougher to Treat for Black Patients
September 22, 2018 - Team reveals that human genome could contain up to 20 percent fewer genes
September 22, 2018 - USC research uncovers previously unknown genetic risk factor for Alzheimer’s disease
September 22, 2018 - Novel method achieves accurate and precise temperature estimation in fat-containing tissues
September 22, 2018 - BSI accredits Oxehealth’s vital signs measurement software as Class IIa medical device
September 22, 2018 - Evolution of psychiatric disorders and human personality traits
September 22, 2018 - Obesity in early puberty doubles asthma risk for boy’s future offspring
September 22, 2018 - World’s most advanced real-time patient monitoring platform receives key US patent
September 22, 2018 - Study explores connection between sexuality and cognitive status in older adults
September 22, 2018 - LSTM partners with TB Alliance to develop novel TB drug regimens
September 22, 2018 - Annual wellness visits improve delivery of preventive services in elderly population
September 22, 2018 - CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma
September 22, 2018 - Hispanic communities with high proportions of Hispanics face more cardiovascular-related death
September 22, 2018 - Vici syndrome – Genetics Home Reference
September 22, 2018 - Single-dose drug can shorten flu symptoms by about a day, studies suggest
September 22, 2018 - AMSBIO launches circulating tumor DNA Reference Standards
September 22, 2018 - Sandalwood mimicking odorant could stimulate hair growth in humans
September 22, 2018 - Overlooked immune cells could play a key role in cancer immunotherapy, claims new study
September 22, 2018 - Study reveals prevalence of diagnosed type 1 and type 2 diabetes among American adults
September 22, 2018 - Researchers develop fast detection strategy to know type of virus acquired by patients
September 22, 2018 - Global Prevalence of Insufficient Activity 27.5 Percent
September 22, 2018 - Strategies to protect bone health in hematologic stem cell transplant recipients
September 22, 2018 - Brigham Genomic Medicine program unravels 30 medical mysteries
September 22, 2018 - New system harnesses power of bubbles to destroy dangerous biofilms
September 22, 2018 - Inflammation plays crucial role in preventing heart attacks and strokes, study reveals
September 22, 2018 - Calorie dense, nutrient deficient meals common across the world
September 22, 2018 - Researchers develop technology to study behavior of implants without animal testing
September 22, 2018 - First gut bacteria in newborns may have lasting effect on ability to ward off chronic diseases
September 22, 2018 - Detection of BFD virus in parrots in 8 new countries raises concerns for threatened species
September 22, 2018 - Insulin treatment shows great potential against chronic bowel inflammation
September 22, 2018 - ‘Liking Gap’ Might Stand in Way of New Friendships
September 22, 2018 - Simple factors that can avoid harmful side effects in type 2 diabetes
September 22, 2018 - ALSAM Foundation invests additional $2 million for drug discovery and development projects
September 22, 2018 - Study findings may advance discussion of how to effectively curb human-wildlife conflict
September 22, 2018 - Dopamine neurons may involve in conditions ranging from Parkinson’s disease to schizophrenia
September 22, 2018 - Protein C and Protein S Tests: MedlinePlus Lab Test Information
September 22, 2018 - Obesity and diabetes—two reasons why we should be worried about the plastics that surround us
September 22, 2018 - Concern over fussy eating prompts parents to use non-responsive feeding practices
September 22, 2018 - Novel mathematical approach uncovers existence of unsuspected biological cycles
September 22, 2018 - Cancer Research UK invests £14 million to transform London into cancer biotherapeutics hub
September 22, 2018 - Scientists predict how well the body will fight lung cancer by analyzing immune cell shapes
September 22, 2018 - New outbreak of rare eye disease identified in contact lens wearers
September 22, 2018 - Iterum Initiates SURE 2 and SURE 3 Phase 3 Clinical Trials of IV and Oral Sulopenem in Complicated Urinary Tract and Complicated Intra-abdominal Infections
September 22, 2018 - Research finds divide in dental health accessibility between city and regional areas
September 22, 2018 - Premature babies show better brain development when fed breast milk, finds study
September 22, 2018 - Novel system uses AI to detect abnormalities in fetal hearts
September 22, 2018 - UNC scientists reveal new approach to prevent obesity and diabetes
September 22, 2018 - CWRU receives NIH grant to learn how non-coding genes contribute to spread of colorectal cancer
September 22, 2018 - Scientists better understand influenza virus and how it spreads
September 22, 2018 - Scientists to focus on length of time when a person is alive and healthy
September 22, 2018 - Study shows positive financial impacts of Medicaid expansion for low-income Michigan residents
September 22, 2018 - Innovative approach for developing vaccine against most prevalent human malaria parasite
September 22, 2018 - New findings on characteristics of Burning Mouth Syndrome
September 22, 2018 - Study sheds light on molecular mechanisms underlying progression of prion diseases
September 22, 2018 - Innovation Fund Denmark supports research project that aims to fight Clostridium difficile diarrhea
September 22, 2018 - Survey estimates caregiving costs for family members
September 22, 2018 - Inhibiting NF-kB improves heart function in a mouse model of Duchenne muscular dystrophy
September 22, 2018 - Introducing new EMR system may affect several aspects of clinic workflow
September 22, 2018 - Study finds why some human genes are more popular with biomedical researchers
September 22, 2018 - Finding epigenetic signature appears to predict inflammation risk in serious type of IBD
September 22, 2018 - Researchers develop light-based technique to measure very weak magnetic fields
September 22, 2018 - UAB researchers study dysfunction of the immune system associated with NSAID carprofen
September 22, 2018 - QIAGEN and DiaSorin launch automated, CE-marked workflow for high-throughput TB screening
September 22, 2018 - EFS checklist provides user-friendly tool for evaluating feeding skills in preterm infants
September 22, 2018 - Family history in blacks, Latinos associated with higher risk of AFib
September 22, 2018 - Researchers identify new genetic disorder in a human patient
September 22, 2018 - Cardiac MR With Contrast Feasible in Developing World
September 22, 2018 - Daily low-dose aspirin doesn’t reduce heart-attack risk in healthy people
September 21, 2018 - Children with asthma found to be disadvantaged in education and future occupation
September 21, 2018 - Interaction of chemical slurry and ancient shale in fracking wastewater causes radioactivity
September 21, 2018 - Scientists use mice to study transmission of Lyme disease bacteria by infected ticks
September 21, 2018 - Researchers find that sample size is key factor determining accuracy of study results
September 21, 2018 - Study shows how the drive to eat overpowers the brain’s signal to stop
September 21, 2018 - 30 Million Americans Now Have Diabetes
September 21, 2018 - Thousands of breast cancer gene variants engineered and analyzed
September 21, 2018 - The current fellowship interview process is cumbersome — Stanford researchers have a better idea
September 21, 2018 - Progenitor cells for human bone and cartilage have been identified
September 21, 2018 - Study reveals new therapeutic target for pediatric tumor-associated intractable epilepsy
September 21, 2018 - SLU’s College professor receives NIH grant to develop I-TEST project
September 21, 2018 - DermTech completes enrollment in clinical study to assess DNA damage and reversal
'Remarkable' effects introduced from new blood most cancers find out about

'Remarkable' effects introduced from new blood most cancers find out about

image_pdfDownload PDFimage_print
Electron microscopic symbol of a unmarried human lymphocyte. Credit score: Dr. Triche Nationwide Most cancers Institute

Scientists have described new result of a blood most cancers find out about as ‘exceptional’ in tackling up to now untreatable kinds of power lymphocytic leukaemia (CLL).

The development led through a crew from the College of Leicester and College Hospitals of Leicester NHS Agree with, inside the Hope Medical Trials Facility, concerned about treating sufferers with CLL.

It follows on from a world-first scientific trial of a brand new drug to regard explicit blood cancers. Result of that global scientific trial, led through Dr Harriet Walter and Professor Martin Dyer have been revealed within the magazine Blood in November 2015 and appeared on the efficacy of a brand new inhibitor, ONO/GS-4059, within the remedy of CLL and Non-Hodgkin Lymphoma sufferers, refractory or proof against present chemotherapies.

ONO/GS-4059 goals BTK, a protein crucial for the survival and proliferation of the tumour cells.

The find out about opened in January 2012 and 90 sufferers have been enrolled in several centres in the United Kingdom and in France, with 28 coming from Leicester. Sufferers with CLL confirmed the most efficient reaction and maximum of them have been nonetheless at the find out about after three years, and remarkably with out notable toxicities.

Within the new paper, the researchers are reporting for the long-term follow-up effects. Their paintings, revealed within the magazine Blood, was once funded through the Ernest and Helen Scott Haematological Analysis Institute, ONO Prescription drugs, Gilead Prescription drugs and the Most cancers Analysis UK Leicester Experimental Most cancers Drugs Centre. Native charity Hope Towards Most cancers fund the Medical Trials Facility based totally on the Leicester Royal Infirmary.

Professor Martin Dyer is Professor of Haemato-Oncology within the Division of Most cancers Research on the College of Leicester and Honorary Guide Doctor within the Division of Haematology at Leicester Royal Infirmary.

He mentioned: “This present paper describes the longer term keep on with up and presentations that during sufferers with CLL the remissions are sturdy and related with out a new toxicities. Moreover, in collaboration with Sistemas Genomicos, an organization in Valencia, we have now proven that mutations related to competitive illness reply neatly to remedy with ONO/GS-4059.

“Our long run keep on with up presentations maintained efficacy with out toxicity. This find out about is the primary document of long run follow-up of a selective BTK inhibitor – and it is superb information for sufferers.

“The consequences we’re presenting are according to a global scientific find out about involving the United Kingdom, France, Japan and US – and led through Leicester.

This was once a Section 1 scientific find out about because of this the researchers are within the early levels of trying out the drug’s effectiveness.

“We are actually doing research of ONO/GS-4059 together with different precision medications to evaluate whether or not those effects will also be enhanced in sufferers with CLL and different B cellular malignancies.”

Native most cancers analysis charity, Hope Towards Most cancers, has been investment a few of Professor Dyer’s paintings. Leader Govt of the charity, Nigel Rose mentioned: “Professor Dyer is a long-standing collaborator and recipient of Hope’s investment. We’re overjoyed that that is being put to such extraordinarily vital use in assembly our charity’s undertaking of bettering the lives of most cancers sufferers in the community.”

Discover additional:
Global-first blood most cancers drug trial finds life-changing effects

Additional info:
Harriet S. Walter et al. Lengthy-term follow-up of sufferers with CLL handled with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059, Blood (2017). DOI: 10.1182/blood-2017-02-765115

Magazine reference:

Equipped through:
College of Leicester

Tagged with:

About author

Related Articles